Eurobio Scientific SA Cash Flow Conversion Efficiency

Latest as of June 2025: 0.030x

Eurobio Scientific SA cash flow conversion efficiency. Based on the latest financial reports, Eurobio Scientific SA (ALERS) has a cash flow conversion efficiency ratio of 0.030x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€5.36 Million ≈ $6.26 Million USD) by net assets (€180.85 Million ≈ $211.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Eurobio Scientific SA (2007–2024)

Cash flow conversion efficiency of Eurobio Scientific SA from 2007 to 2024. This chart illustrates how Eurobio Scientific SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Eurobio Scientific SA stock price for real-time trading data and today's change.

Eurobio Scientific SA Cash Flow Conversion Ratio Explained

Eurobio Scientific SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Eurobio Scientific SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eurobio Scientific SA ranked by their cash flow conversion efficiency. Also see Eurobio Scientific SA market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Quarterhill Inc
TO:QTRH
0.073x
PharmaEngine
TWO:4162
0.011x
Aurora Cannabis Inc
NASDAQ:ACB
-0.008x
Zhejiang Power New Energy Co. Ltd. A
SHG:688184
N/A
BRT Realty Trust
NYSE:BRT
0.040x
Creotech Quantum SA
WAR:CRQ
N/A
Hyundai Cement
KO:006390
0.059x
Illumination Acquisition Corp I Class A Ordinary Shares
NASDAQ:ILLU
N/A

Annual Cash Flow Conversion Efficiency for Eurobio Scientific SA (2007–2024)

The table below shows the annual cash flow conversion efficiency of Eurobio Scientific SA from 2007 to 2024. Review Eurobio Scientific SA free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €178.85 Million
≈ $209.10 Million
€16.70 Million
≈ $19.53 Million
0.093x -38.88%
2023-12-31 €175.17 Million
≈ $204.80 Million
€26.77 Million
≈ $31.29 Million
0.153x -38.74%
2022-12-31 €172.67 Million
≈ $201.87 Million
€43.07 Million
≈ $50.36 Million
0.249x -39.36%
2021-12-31 €160.22 Million
≈ $187.32 Million
€65.92 Million
≈ $77.06 Million
0.411x -19.23%
2020-12-31 €107.84 Million
≈ $126.08 Million
€54.93 Million
≈ $64.22 Million
0.509x +273.22%
2019-12-31 €36.56 Million
≈ $42.75 Million
€4.99 Million
≈ $5.83 Million
0.136x +872.96%
2018-12-31 €29.62 Million
≈ $34.63 Million
€-523.00K
≈ $-611.44K
-0.018x -122.61%
2017-12-31 €31.69 Million
≈ $37.05 Million
€2.48 Million
≈ $2.89 Million
0.078x +128.78%
2016-12-31 €12.23 Million
≈ $14.29 Million
€-3.32 Million
≈ $-3.88 Million
-0.271x -158.84%
2015-12-31 €23.31 Million
≈ $27.25 Million
€-2.44 Million
≈ $-2.86 Million
-0.105x +13.43%
2014-12-31 €27.95 Million
≈ $32.67 Million
€-3.38 Million
≈ $-3.96 Million
-0.121x +49.18%
2013-12-31 €20.56 Million
≈ $24.04 Million
€-4.90 Million
≈ $-5.73 Million
-0.238x -31.31%
2012-12-31 €24.50 Million
≈ $28.64 Million
€-4.45 Million
≈ $-5.20 Million
-0.182x +59.12%
2011-12-31 €13.57 Million
≈ $15.86 Million
€-6.02 Million
≈ $-7.04 Million
-0.444x -46.82%
2010-12-31 €19.19 Million
≈ $22.44 Million
€-5.80 Million
≈ $-6.78 Million
-0.302x -14.79%
2009-12-31 €25.46 Million
≈ $29.76 Million
€-6.71 Million
≈ $-7.84 Million
-0.263x +73.33%
2008-12-31 €9.74 Million
≈ $11.39 Million
€-9.62 Million
≈ $-11.24 Million
-0.988x -261.60%
2007-12-31 €18.07 Million
≈ $21.12 Million
€-4.93 Million
≈ $-5.77 Million
-0.273x --

About Eurobio Scientific SA

PA:ALERS France Medical Devices
Market Cap
$310.16 Million
€265.30 Million EUR
Market Cap Rank
#15635 Global
#229 in France
Share Price
€26.35
Change (1 day)
+0.00%
52-Week Range
€19.20 - €26.40
All Time High
€28.88
About

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monito… Read more